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pression may be applied to stratify risk in inferior MI patients.
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Conclusions: There are substantial variations in the use of cardiac proce-
dures across the US. The lower use of cardiac procedures in New England
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Coronary Artery Bypass Graft Surgery in the United
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West Great Mid Mid Mid New South South
% Lake Atlan. South West Eng!. East West
CATH 67 80 73 86 77 56 79 77
PlCA 25 32 32 35 36 22 35 35
CA8G 12 14 12 16 15 10 15 15
Death 6.2 6.7 7.2 55 7.7 68 7.6 60
MI 3.1 3.6 39 35 42 3.9 4.1 3.3
Invasive management of coronary artery disease (CAD) includes Percuta-
neous Transluminal Coronary Angioplasty (PTCA) and Coronary Artery By-
pass Graft surgery (CABG). Indications for CABG and PTCA are well estab-
lished. Whether PTCA alters the incidence of CABG is unknown. If PTCA is
an effective invasive alternative to CABG, then where PTCA is aggressively
performed, rates of CABG should be lower than in other locations with lower
PTCA rates. We tested whether the performance of PTCA decreases the in-
cidence of CABG comparing practice patterns in all 50 States. We examined
the Medicare volume of PTCA from 805 hospitals and of CABG from 783
hospitals in the United States (US) from the Health Care Financing Adminis-
tration (HCFA) database for 1992. Volumes of procedures were aggregated
by State. Census data for population age >65 was obtained from the US
Census Bureau for 1990. For all 50 States, as the rate of PTCA per 100,000
population age >65 (PTCA/l 00,000) increased, there was an increase in the
rate of CABG per 100,000 population age >65 (CABG/l 00,000) (r2 = 0.67,P
< 0.0001) with rates of PTCA/l 00,000 and CABG/l 00,000 ranging from 89 to
831 and 299 to 1108 respectively. For the 10 States with the greatest pop-
ulation age >65 years, the relationship was similar (r2 = 0.84,P = 0.0002)
with rates of PTCA/l 00,000 and CABG/l 00,000 ranging from 130 to 503 and
from 378 to 764 respectively. We conclude: 1) Rates of PTCA/I00,000 and
CABGIl 00,000 vary considerably from State to State despite established in-
dications, 2) High rates of PTCA/I00,000 are associated with high rates of
CABGIl 00,000 suggesting that PTCA does not substitute for CABG in the in-
vasive treatment of CAD, 3) Among the 10 most populous States, low rates
of both procedures were associated with a Certificate of Need program and
public disclosure of hospital and physician volume and mortality results for
CABG surgery, 4) Appropriateness studies for PTCA and CABG should be
performed on an individual statewide basis to further investigate the consid-
erable inter-state variability.
Louise Pilote, Amanda Stebbins, Daniel B. Mark, Robert M. Califf, Eric J. Topol,
GUSTO Investigators. Cleveland Clinic Foundation, Cleveland, OH
Background: Little is known about regional variations in the treatment of
acute myocardial infarction (MI) after thrombolysis in the United States (US).
Methods: We performed secondary analyses of the GUSTO data, a random-
ized trial of thrombolytic strategies. We compared use of cardiac procedures
in 8 US regions (West, n = 2198, Great Lakes, n = 3155, Mid Atlantic, n =
3130, Mid South, n = 1724, Mid West, n = 2498, New England, n = 4369,
South East, n = 3447 and South West. n = 2584). Results: Compared to
other US regions, the proportion of patients undergoing cardiac procedures
was lowest in New England (Table). Coronary angiography (CATH) use was
lowest in New England 156%) and highest in the Mid South (86%). Coronary
angioplasty (PTCA) use was lowest in New England (22%) and highest in the
Mid West (36%). Coronary artery bypass surgery (CABG) was lowest in New
England (10%) and highest in the Mid South (16%). These differences were
not explained by demographic or clinical characteristics. The 30 day mortality
and recurrent MI rates were similar across regions.
10:45
1791-2\ Regional Variations in the Use of Cardiac Procedures
After Thrombolysis: New England is an Outlier in the
GUSTO Trial
95% Confidence Interval
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089-13.1
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094-859
Odds Ratio
2.39
3.42
13.4
233
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2.99
1.28
0.85
1.72
2.84
Sex (Females vs. Males)
Age (years): (61J-<j9 vs. <60)
1,,:70 vs. <60)
Previous Myocardial Infarction
Diabetes Mellitus
Killip on Admission (> 1vs. 1)
Peak CK Level (per 1000 IU)
Group B versus Group A
Group Cversus Group A
Group D versus Group A
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In the pre-thrombolytic era the occurrence of new bundle branch block in the
setting of acute myocardial infarction ranged between 6 to 12%. Whether
thrombolytic therapy alter the incidence and clinical relevance of bundle
branch block during acute myocardial infarction is unclear. In 324 consec-
utive patients with acute myocardial infarction admitted under the Gusto I
protocol the incidence of new onset bundle branch block (BBB) was exam-
ined with respect to the infarct related artery liRA). Each patient underwent
continuous 12 lead ECG rnonitoring for a period of 24 - 72 hours using a
system which stored any ST change persisting for more than 60 seconds.
Of the 324 patients, the overall incidence of BBB was found to be 28% (n
= 91). transient BBB was seen in 24.3% In = 79) of patients, persistent BBB
in 3.7% (n = 12) and alternating right and left BBB in 2.2% In = 71. When
examined with respect to the infarct related artery, patients with LAD infarcts
had a higher incidence of BBB as compared to those with infarcts in the
RCA/Circumflex distribution (LAD 39% vs. RCA 26% and Circumflex 15.6%,
p < 0.05). The occurrence of right or left BBB was not predicted based on
the infarct related artery, being equally distributed in patients with LAD/RCA
infarcts. Mortality in the overall population was 5% (n = 16). Persistent BBB,
irrespective of the infarct related artery, was predictive of a higher mortality
(33% = 4/12) than transient 15% = 4/79), or no BBB (3.4% = 8/233) (p <
0.01).
In conclusion: 1) In this population, the occurrence of persistent BBB is
lower than previously reported. Whether this is secondary to the use of
thrombolytic agents requires further evaluation. 2) LAD occlusion is asso-
ciated with a higher incidence of BBB. 3) The occurrence of either right or
left 8BB was not predicted by the occluded artery. 4) Persistent BBB predicts
a worse prognosis.
Conclusions: pts with IAMI and maximal ST depression in left precordial
leads in the admission ECG, are at high risk for 3D-day mortality, while ST de-
pression in the right precordial leads (Vl-V3) is not associated with increased
risk.
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The Incidence and Clinical Relevance of Bundle
Branch Block in Patients with Acute Myocardial
Infarction Treated with Thrombolytic Agents
Previous studies have shown that ST depression in the precordial leads in
inferior wall acute myocardial infarction (lAM I) is associated with increased
in hospital mortality. However, no distinction has been made between max-
imal ST depression in the right versus left precordial leads. This study as-
sesses the correlation between the pattern of precordial ST depression in
the admission ECG and 3D-day mortality in 1321 pts with IAMI. All pts were
admitted within 6 hours from onset of symptoms and received either STK or
tPA intravenously. Only pts with ST elevation ,,=0.1 mV and positive T waves
in at least two of the inferior leads were included. Pts were allocated into 4
groups: group A-no precordial ST depression (n ~ 346); group B-sum of ST
depression in right leads (VI-V3) greater than the sum in left leads (V4-V6)
(n = 700); group C-surn of ST depression in right leads equal to the surn in
left leads (n = 1621; and group D-rnaximal ST depression in V4-V6In = 113).
A total of 48 pts (3.6%) died. The mortality for group A, B, C, and D were
10 (2.9%), 20 (2.8%), 7 (4.3%), and 11 (9.7%), respectively. Using logistic
regression model, only the following parameters were found to be indepen-
dent predictors for 3D-days mortality;
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may be related to a more restrictive regional approach and does not appear
to affect clinical outcomes including 30 day-mortality and recurrent MI.
Conclusion: Marked differences are present among these 3 scoring sys-
tems. Factors contributing to these differences should be clarified before
they are widely applied 10 patient care.
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Physician Profiles of Coronary Revascularization in
the Emory Angloplasty vs Surgery Trial:
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Prospective Application of RAND Expert Panel
Ratings, ACC/AHA Guidelines, and the University of
Maryland Revascularizatlon Appropriateness Score
(RAS): Only RAS Predicts Clinical Outcome
Understanding the reasons for variations in physician resource utilization in
coronary angioplasty (PlCA) and coronary surgery (CABG) is essential to ef-
ficiently organizing, managing, and paying for these procedures. lo evaluate
the extent of variations in physician resource utilization for CABGs and PlCAs
and the reasons for these variations, the resource-based relative value scale
(RBRVS), an index of relative weights for physician work and practice costs,
is used to evaluate physician practice patterns. Given their extensive clinical
review, RBRVS weights represent new, unique, comprehensive measures of
physician resource utilization where 1 unit value is equivalent to an interme-
diate office visit for an established patient. Our investigation uses 3 years of
clinical and financial data on 392 randomized patients with multivessel coro-
nary artery disease (EASl data). receiving the initial therapy of either CABG
or PlCA. RBRVS weights are assigned to each procedure code (CPl) and
the distribution of RBRVS units and their allocation among different types
of services are analyzed. Results show significant differences in physician
resources for both CABGs and PlCAs. Among CABG patients, nearly a nine-
fold variation in physician resource units is evident (108 ± 46) and, for PlCA,
a 29-fold variation exists (66 ± 54). At three years, the average physician re-
source utilization for CABG is 64% greater than PlCA. Significant differences
are also evident in surgical, laboratory, imaging, and consult resources even
after accounting for casemix. The findings demonstrate that the RBRVS is a
viable and useful analytical tool for managerial and clinical personnel.
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Several scoring systems exist for evaluating the appropriateness of PlCA
and CABG. However, they have not been prospectively correlated with out-
come. We prospectively studied 61 pts referred to the catheterization labo-
ratory who were treated with PlCA (33). CABG (15) or medical therapy (13).
Forty-five were male; the mean age was 60.2 ± 12.8 years (range 32-87). Dur-
ing a mean followup of 9.3 ± 3.8 months {range 3-16.1),66 events occurred
in 35 patients including angina (25), MI (3), death (6), cardiac readmission
{171. PlCA (4), CABG (7), CHF (4).
For all patients, revascularization appropriateness was ranked by the RAS,
ACC/AHA. and RAND Scoring systems. Application of RAS yielded revascu-
larization appropriateness ratings of Necessary (N), Appropriate (AI, or Inap-
propriate (I). Of 11 patients ranked N who did not receive revascularization, 10
had adverse events, compared with 17 of 35 who received revascularization
(p = 0.02). Of 5 pts ranked I for revascularization who received either PlCA
or CABG, 3 had adverse events. In total, 13 of 16 pts who received treatment
that was discordant with a N or I RAS rating had adverse events, compared
with 20 of 45 who received concordant treatment. (p = 0.021. These dis-
cordant treatments included unnecessary PlCA (5). failure to perform CABG
(1), PlCA (3), or either (7). Statistical significance persisted when only "hard"
events (excluding angina) were considered (p = 0.03). Concordance of treat-
ment with RAND and ACC/AHA revascularization appropriateness scores for
PlCA and CABG were not predictive of adverse events in this population.
Conclusion: Revascularization appropriateness scoring systems differ in
their ability to predict outcomes. Of the 3 approaches studied, only treatment
concordant with RAS treatment recommendations reduced subsequent ad-
verse events.
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Although different scoring systems have been used to evaluate the appro-
priateness of PlCA and CABG, they have not been directly compared. For
100 patients referred to the catheterization laboratory, we prospectively com-
pared the RAND Expert Panel Ratings, ACC/AHA Guidelines and the Univer-
sity of Maryland Revascularization Appropriateness Score (RAS). The patient
population included stable angina (25%), unstable angina (33%). post-MI
(27%), acute MI (7%). asymptomatic with + En or pre-op (7%). and sud-
den death (1 %). Pts were treated with PlCA(62%). CABG (19%), or medical
therapy(19%).
There were significant differences among the 3 systems for PlCA and
CABG appropriateness. ACC/AHA and RAS were more definitive in assigning
revascularization scores than RAND which yielded uncertain ratings in 17%
for CABG and 38% for PlCA. ACC/AHA differed markedly in the Inappropri-
ate/Class III rating for both CABG and PlCA.
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The Influence of Clinical Risk Factors on the Use of
Angiography and Revascularizatlon After Acute
Myocardial Infarction
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Prospective Assessment of Revascularization
Appropriateness Scoring Systems: A Comparison of
RAND Expert Panel Ratings, ACC/AHA Guidelines,
and the University of Maryland Revascularization
Appropriateness Score
Michael A. Lauer, Andrew A. Ziskind, Cynthia C. Lemmon, Robert A. Vogel
University of Maryland, Baltimore, Maryland
After acute myocardial infarction (AMI). the American College of Cardiology
and the American Heart Association recommend angiography in patients "if
the prognosis is judged to be poor ... and ... outcome can be improved by
urgent bypass surgery or coronary angioplasty (PlCA)." In 4823 consecutive
survivors of AMI, we examined the relationship between both angiography
(n = 2274) and revascularization (n = 692 for PlCA, n = 469 for bypass
surgery) and 7 clinical variables that predict mortality (age, recurrent angina,
ejection fraction, heart failure, use of thrombolytics, prior infarction, cardio-
genic shock).
Multivariate logistic regression revealed that except for recurrent angina,
most factors predicting higher mortality were associated with a lower use of
angiography (OR(95%CI) = 2.75 (2.39-3.17) for recurrent angina, 0.47 (0.43-
0.51) for older age, 0.85 (0.74-0.97) for prior infarction, 0.50 (0.43--0.59) for no
thrombolytic treatment, and 0.63 (0.5S--O.73) for heart failure during hospital-
ization). A similar relationship was observed among patients who underwent
PlCA (OR(95%CI) = 1.94 (1.53-2.47) for recurrent angina, 0.51 (0.40-0.65)
for low ejection fraction, 0.72 (0.57--0.93) for no thrombolytic therapy and
0.74 (0.56--0.98) for history of prior infarction). In contrast, patients with un-
favorable prognostic profiles were more likely to undergo coronary bypass
surgery (OR(95%CI) = 1.66 (1.34-2.06) for recurrent angina, 1.28 (1.11-1.47)
for older age, 2.24 (1.78-2.82) for heart failure, 1.46 (1.18-1.80) for prior in-
farction and 1.28 for no thrombolytic therapy).
Angiography and PlCA are performed more often in patients who are at
relatively low risk for subsequent mortality. Since there is currently no evi-
dence of a survival advantage from PlCA, the risks of this procedure could
be avoided in some patients by initially treating them conservatively and sub-
sequently performing PlCA in only those patients whose symptoms are not
controlled with medications alone.
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